KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Share-based Compensation: 2020-2025

Historic Share-based Compensation for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $17.8 million.

  • Ginkgo Bioworks Holdings' Share-based Compensation rose 28.77% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year decrease of 39.77%. This contributed to the annual value of $112.3 million for FY2024, which is 51.13% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Share-based Compensation is $17.8 million, which was down 19.80% from $22.2 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Share-based Compensation registered a high of $1.6 billion during Q4 2021, and its lowest value of $118,000 during Q1 2021.
  • Moreover, its 3-year median value for Share-based Compensation was $37.1 million (2024), whereas its average is $36.6 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Share-based Compensation soared by 1,348,422.03% in 2021, and later crashed by 93.20% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Share-based Compensation (Quarterly) stood at $1.6 billion in 2021, then plummeted by 93.20% to $108.2 million in 2022, then tumbled by 60.40% to $42.8 million in 2023, then tumbled by 52.00% to $20.6 million in 2024, then rose by 28.77% to $17.8 million in 2025.
  • Its Share-based Compensation stands at $17.8 million for Q3 2025, versus $22.2 million for Q2 2025 and $20.4 million for Q1 2025.